 Immunovative Therapies, Ltd. is a privately-held Israeli biopharmaceutical company that operates out of laboratories at Hadassah-Hebrew University Medical Center with headquarters in Shoham, Israel (near the Ben Gurion international airport). We have over 70 individual private shareholders that support our development efforts as well as grant support from the Israel Office of the Chief Scientist. We currently have private placements open for financing our planned clinical testing activities. These funds are being sought to support the expansion of our clinical trials to the United States and the European Union. For more information on investment opportunities please contact us at: investors@immunovative.co.il
|